TCM
CPIX icon

True Capital Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

True Capital Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,025
Closed -$27.1K – 130
2022
Q4 		$27.1K Buy
+12,025
New +$27.9K 0.02% 121

Other funds holding CPIX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

True Capital Management's CPIX Position: Q1 2023 in Review

True Capital Management sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2023, closing a stake of 12,025 shares — an estimated $27.1K sold.

True Capital Management first reported a position in CPIX in Q4 2022 and held it in 1 quarter. The position peaked at $27.1K in Q4 2022. 21 funds tracked by Wall St. Rank hold CPIX as of Q1 2023.

  • True Capital Management reported no remaining Cumberland Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • True Capital Management sold 12,025 Cumberland Pharmaceuticals shares in Q1 2023, an estimated $27.1K.
  • True Capital Management first reported a position in Cumberland Pharmaceuticals in Q4 2022 and held it in 1 quarter.
  • True Capital Management's Cumberland Pharmaceuticals position peaked at $27.1K in Q4 2022.
  • 21 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2023.

Based on True Capital Management's 13F filing for Q1 2023, filed 2 May 2023.